A63T (p.Ala63Thr) variant of DCC (Netrin receptor DCC)

A63T (p.Ala63Thr) in DCC (Netrin receptor DCC) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.46 / 1. The record also includes population frequency data and structural context.

A63T (p.Ala63Thr) variant details